Effect of subanesthetic ketamine on intrinsic functional brain connectivity: A placebo-controlled functional magnetic resonance imaging study in healthy male volunteers

Anesthesiology

Volumn 117, Issue 4, 2012, Pages 868-877

  Niesters, Marieke ^a   Khalili Mahani, Najmeh ^a,b   Martini, Christian ^a   Aarts, Leon ^a   Van Gerven, Joop ^a   Van Buchem, Mark A ^b   Dahan, Albert ^a   Rombouts, Serge ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESKETAMINE; PLACEBO;

ADULT; AMYGDALOID NUCLEUS; ANALGESIA; ANTERIOR CINGULATE; ARTICLE; BRAIN FUNCTION; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; DRUG EFFECT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; INSULA; INTRINSIC FUNCTIONAL BRAIN CONNECTIVITY; LOW DRUG DOSE; MALE; NOCICEPTION; NORMAL HUMAN; ORBITAL CORTEX; PAIN ASSESSMENT; PRIORITY JOURNAL; STEADY STATE; VISUAL CORTEX;

ADULT; ANESTHETICS, DISSOCIATIVE; BRAIN; DATA INTERPRETATION, STATISTICAL; HALLUCINOGENS; HOT TEMPERATURE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; KETAMINE; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; NERVE NET; PAIN; PAIN MEASUREMENT; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 84866734199     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e31826a0db3     Document Type: Article

References (50)

1. Noppers I, Niesters M, Aarts L, Smith T, Sarton E, Dahan A: Ketamine for the treatment of chronic non-cancer pain. Expert Opin Pharmacother 2010; 11:2417-29
2. Brown EN, Purdon PL, Van Dort CJ: General anesthesia and altered states of arousal: A systems neuroscience analysis. Annu Rev Neurosci 2011; 34:601-28
3. Nagels A, Kirner-Veselinovic A, Krach S, Kircher T: Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency. NeuroImage 2011; 54:1307-14
4. Rogers R, Wise RG, Painter DJ, Longe SE, Tracey I: An investigation to dissociate the analgesic and anesthetic properties of ketamine using functional magnetic resonance imaging. ANESTHESIOLOGY 2004; 100:292-301 (Pubitemid 38133696)
5. Yu H, Li Q, Wang D, Shi L, Lu G, Sun L, Wang L, Zhu W, Mak YT, Wong N, Wang Y, Pan F, Yew DT: Mapping the central effects of chronic ketamine administration in an adolescent primate model by functional magnetic resonance imaging (fMRI). Neurotoxicology 2012; 33:70-7
6. Långsjö JW, Kaisti KK, Aalto S, Hinkka S, Aantaa R, Oikonen V, Sipilä H, Kurki T, Silvanto M, Scheinin H: Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans. ANESTHESIOLOGY 2003; 99:614-23 (Pubitemid 37051976)
7. Långsjö JW, Salmi E, Kaisti KK, Aalto S, Hinkka S, Aantaa R, Oikonen V, Viljanen T, Kurki T, Silvanto M, Scheinin H: Effects of subanesthetic ketamine on regional cerebral glucose metabolism in humans. ANESTHESIOLOGY 2004; 100: 1065-71 (Pubitemid 38541959)
8. Långsjö JW, Maksimow A, Salmi E, Kaisti K, Aalto S, Oikonen V, Hinkka S, Aantaa R, Sipilä H, Viljanen T, Parkkola R, Scheinin H: S-ketamine anesthesia increases cerebral blood flow in excess of the metabolic needs in humans. ANESTHESIOLOGY 2005; 103:258-68 (Pubitemid 41076722)
9. Mesulam MM: From sensation to cognition. Brain 1998; 121: 1013-52
10. Khalili-Mahani N, Zoethout RM, Beckmann CF, Baerends E, de Kam ML, Soeter RP, Dahan A, van Buchem MA, van Gerven JM, Rombouts SA: Effects of morphine and alcohol on functional brain connectivity during "resting state": A placebo-controlled crossover study in healthy young men. Hum Brain Mapp 2012; 33:1003-18
11. Smith SM, Fox PT, Miller KL, Glahn DC, Fox PM, Mackay CE, Filippini N, Watkins KE, Toro R, Laird AR, Beckmann CF: Correspondence of the brain's functional architecture during activation and rest. Proc Natl Acad Sci 2009; 106: 13040-5
12. Damoiseaux JS, Rombouts SA, Barkhof F, Scheltens P, Stam CJ, Smith SM, Beckmann CF: Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci 2006; 103:13848-53
13. Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy-Byrne PP: Psychedelic effects of ketamine in healthy volunteers: Relationship to steady-state plasma concentrations. ANESTHESIOLOGY 1998; 88:82-8
14. Zuurman L, Roy C, Schoemaker RC, Hazekamp A, den Hartigh J, Bender JC, Verpoorte R, Pinquier JL, Cohen AF, van Gerven JM: Effect of intrapulmonary tetrahydrocannabinol administration in humans. J Psychopharmacol 2008; 22: 707-16
15. Beckmann CF, DeLuca M, Devlin JT, Smith SM: Investigations into resting-state connectivity using independent component analysis. Philos Trans R Soc Lond B Biol Sci 2005; 360:1001-13 (Pubitemid 41672861)
16. Smith SM, Nichols TE: Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage 2009; 44: 83-98
17. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, Bannister PR, De Luca M, Drobnjak I, Flitney DE, Niazy RK, Saunders J, Vickers J, Zhang Y, De Stefano N, Brady JM, Matthews PM: Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004; 23(Suppl 1):S208-19 (Pubitemid 39421720)
18. Biswal BB, Mennes M, Zuo XN, Gohel S, Kelly C, Smith SM, Beckmann CF, Adelstein JS, Buckner RL, Colcombe S, Dogonowski AM, Ernst M, Fair D, Hampson M, Hoptman MJ, Hyde JS, Kiviniemi VJ, Kötter R, Li SJ, Lin CP, Lowe MJ, Mackay C, Madden DJ, Madsen KH, Margulies DS, Mayberg HS, McMahon K, Monk CS, Mostofsky SH, Nagel BJ, Pekar JJ, Peltier SJ, Petersen SE, Riedl V, Rombouts SA, Rypma B, Schlaggar BL, Schmidt S, Seidler RD, Siegle GJ, Sorg C, Teng GJ, Veijola J, Villringer A, Walter M, Wang L, Weng XC, Whitfield-Gabrieli S, Williamson P, Windischberger C, Zang YF, Zhang HY, Castellanos FX, Milham MP: Toward discovery science of human brain function. Proc Natl Acad Sci 2010; 107:4734-9
19. Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A, Tyacke RJ, Leech R, Malizia AL, Murphy K, Hobden P, Evans J, Feilding A, Wise RG, Nutt DJ: Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci U S A 2012; 109:2183-43
20. Benarroch EE: NMDA receptors: Recent insights and clinical correlations. Neurology 2011; 76:1750-7
21. Rigby M, Le Bourdellès B, Heavens RP, Kelly S, Smith D, Butler A, Hammans R, Hills R, Xuereb JH, Hill RG, Whiting PJ, Sirinathsinghji DJ: The messenger RNAs for the N-methyl-Daspartate receptor subunits show region-specific expression of different subunit composition in the human brain. Neuroscience 1996; 73:429-47 (Pubitemid 26168802)
22. Wolf U, Rapoport MJ, Schweizer TA: Evaluating the affective component of the cerebellar cognitive affective syndrome. J Neuropsychiatry Clin Neurosci 2009; 21:245-53
23. Swartjes M, Morariu A, Niesters M, Aarts L, Dahan A: Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain. ANESTHESIOLOGY 2011; 115:165-74
24. Musso F, Brinkmeyer J, Ecker D, London MK, Thieme G, Warbrick T, Wittsack HJ, Saleh A, Greb W, de Boer P, Winterer G: Ketamine effects on brain function-simultaneous fMRI/EEG during a visual oddball task. NeuroImage 2011; 58:508-25
25. Abel KM, Allin MP, Kucharska-Pietura K, David A, Andrew C, Williams S, Brammer MJ, Phillips ML: Ketamine alters neural processing of facial emotion recognition in healthy men: An fMRI study. Neuroreport 2003; 14:387-91 (Pubitemid 36337936)
26. Dawson N, Morris BJ, Pratt JA: Subanesthetic ketamine treatment alters prefrontal cortex connectivity with thalamus and ascending subcortical systems. Schizophren Bull 2011; [Epub ahead of print]
27. Fu CH, Abel KM, Allin MP, Gasston D, Costafreda SG, Suckling J, Williams SC, McGuire PK: Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: A functional magnetic resonance imaging study. Psychopharmacology 2005; 183:92-102 (Pubitemid 41484186)
28. Nagels A, Kirner-Veselinovic A, Wiese R, Paulus FM, Kircher T, Krach S: Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency. Eur Arch Psychiatry Clin Neurosci 2011; [Epub ahead of print]
29. Deakin JF, Lees J, McKie S, Hallak JE, Williams SR, Dursun SM: Glutamate and the neural basis of the subjective effects of ketamine: A pharmaco-magnetic resonance imaging study. Arch Gen Psychiatry 2008; 65:154-64 (Pubitemid 351214314)
30. Stone JM, Abel KM, Allin MP, van Haren N, Matsumoto K, McGuire PK, Fu CH: Ketamine-induced disruption of verbal self-monitoring linked to superior temporal activation. Pharmacopsychiatry 2011; 44:33-48
31. May A: Neuroimaging: Visualising the brain in pain. Neurol Sci 2007; 28:S101-7 (Pubitemid 46813636)
32. Sprenger T, Valet M, Woltmann R, Zimmer C, Freynhagen R, Kochs EF, Tölle TR, Wagner KJ: Imaging pain modulation by subanesthetic S-ketamine. Anesth Analg 2006; 103: 729-37 (Pubitemid 44548951)
33. Shih YY, Chang C, Chen JC, Jaw FS: BOLD fMRI mapping of brain responses to nociceptive stimuli in rats under ketamine anesthesia. Med Eng Phys 2008; 30:953-8
34. Ossipov MH, Dussor GO, Porreca F: Central modulation of pain. J Clin Invest 2010; 120:3779-87
35. Moont R, Crispel Y, Lev R, Pud D, Yarnitsky D: Temporal changes in cortical activation during conditioned pain modulation (CPM), a LORETA study. Pain 2011; 152:1469-77
36. Derbyshire SW, Osborn J: Offset analgesia is mediated by activation in the region of the periaqueductal grey and rostral ventromedial medulla. NeuroImage 2009; 47:1002-6
37. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, Büchel C: Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron 2009; 63:533-43
38. Bingel U, Lorenz J, Schoell E, Weiller C, Büchel C: Mechanisms of placebo analgesia: RACC recruitment of a subcortical antinociceptive network. Pain 2006; 120:8-15 (Pubitemid 43078587)
39. Ploner M, Lee MC, Wiech K, Bingel U, Tracey I: Prestimulus functional connectivity determines pain perception in humans. PNAS 2010; 107:355-60
40. King CD, Wong F, Currie T, Mauderli AP, Fillingim RB, Riley JL 3rd: Deficiency in endogenous modulation of prolonged heat pain in patients with irritable bowel syndrome and temporomandibular disorder. Pain 2009; 143:172-8
41. Niesters M, Hoitsma E, Sarton E, Aarts L, Dahan A: Offset analgesia in neuropathic pain patients and effect of treatment with morphine and ketamine. ANESTHESIOLOGY 2011; 115:1063-71
42. Schrouff J, Perlbarg V, Boly M, Marrelec G, Boveroux P, Vanhaudenhuyse A, Bruno MA, Laureys S, Phillips C, Pélé- grini-Issac M, Maquet P, Benali H: Brain functional integration decreases during propofol-induced loss of consciousness. NeuroImage 2011; 57:198-205
43. Boveroux P, Vanhaudenhuyse A, Bruno MA, Noirhomme Q, Lauwick S, Luxen A, Degueldre C, Plenevaux A, Schnakers C, Phillips C, Brichant JF, Bonhomme V, Maquet P, Greicius MD, Laureys S, Boly M: Breakdown of within- and betweennetwork resting state functional magnetic resonance imaging connectivity during propofol-induced loss of consciousness. ANESTHESIOLOGY 2010; 113:1038-53
44. Chamberlin NL, Eikermann M: This is no humbug: Anesthetic agent-induced unconsciousness and sleep are visibly different. ANESTHESIOLOGY 2010; 113:1007-9
45. Sigtermans M, Dahan A, Mooren R, Bauer M, Kest B, Sarton E, Olofsen E: S-ketamine effect on experimental pain and cardiac output: A population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers. ANESTHESIOLOGY 2009; 111:892-903
46. Sigtermans MJ, van Hilten JJ, Bauer MC, Arbous MS, Marinus J, Sarton EY, Dahan A: Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain 2009; 145:304-11
47. Niesters M, Dahan A, Swartjes M, Noppers I, Fillingim RB, Aarts L, Sarton EY: Effect of ketamine on endogenous pain modulation in healthy volunteers. Pain 2011; 152:656-63
48. Strayer RJ, Nelson LS: Adverse events associated with ketamine for procedural sedation in adults. Am J Emerg Med 2008; 26:985-1028
49. Eikermann M, Grosse-Sundrup M, Zaremba S, Henry ME, Bittner EA, Hoffmann U, Chamberlin NL: Ketamine activates breathing and abolishes the coupling between loss of consciousness and upper airway dilator muscle dysfunction. ANESTHESIOLOGY 2012; 116:35-46
50. Bourke DL, Malit LA, Smith TC: Respiratory interactions of ketamine and morphine. ANESTHESIOLOGY 1987; 66:153-6 (Pubitemid 17014444)